Table 1.
Characteristics | SLE | LN | Control | p Significance |
---|---|---|---|---|
Men: women | 17/59 | 11/62 | 10/50 | >0.05 |
Age (years old) | 43.0 ± 6.5 | 44.1 ± 5.6 | 41.7 ± 6.5 | >0.05 |
SLEDAI | 9.4 ± 4.1 | 12.9 ± 3.9 | - | - |
Disease duration (years) | 5.7 ± 1.4 | 6.5 ± 1.1 | - | - |
Clinical presentation (%) | ||||
Constitutional manifestations | ||||
Fatigue | 37.4 | 39.7 | - | >0.05 |
Fever | 11.2 | 9.5 | - | >0.05 |
Weight loss | 7.1 | 5.7 | - | >0.05 |
Cutaneous-mucosal lesions | ||||
Vespertilio | 38.4 | 33.7 | - | >0.05 |
Photosensitivity | 33.9 | 31.4 | - | >0.05 |
Hyperkeratosis/cutaneous atrophy | 27.1 | 22.8 | - | >0.05 |
Depigmentation | 14.5 | 12.6 | - | >0.05 |
Digital ulcerations | 8.2 | 7.3 | - | >0.05 |
Mucosal ulcerations | 11.4 | 9.8 | - | >0.05 |
Alopecia | 24.1 | 21.9 | - | >0.05 |
Musculoskeletal manifestations | ||||
Arthritis/arthralgia | 39.7 | 36.4 | - | >0.05 |
Myositis | 21.1 | 17.2 | - | >0.05 |
Systolic pressure (mm Hg) | 11.9 ± 1.6 | 13.1 ± 1.4 | 11.7 ± 2.3 | >0.05 |
Diastolic pressure (mm Hg) | 6.8 ± 0.8 | 7.1 ± 0.8 | 6.9 ± 0.9 | >0.05 |
Laboratory data | ||||
Leukocytes (cells/mmc) | 3700 ± 2103 | 4022 ± 1051 | 5426 ± 1210 | >0.05 |
Hemoglobin (g/dL) | 10.7 ± 1.4 | 10.1 ± 1.1 | 13.1 ± 1.3 | >0.05 |
Urea (mg/dL) | 28.5 ± 11.7 | 36.0 ± 12.5 | 22.5 ± 7.6 | >0.05 |
Creatinine (mg/dL) | 0.9 ± 0.11 | 1.27 ± 0.19 | 0.68 ± 0.19 | >0.05 |
eGFR (ml/min/1.73mp) | 79.4 ± 16.8 | 44.7 ± 12.6 | 87.5 ± 14.2 | >0.05 |
Hematuria (sw—RBC/camp) | 5 ± 2 | 37 ± 8 | 1 ± 1 | >0.05 |
Leukocyturia (sw—leuc/camp) | 10 ± 2 | 9.3 ± 1.9 | 3.8 ± 2.9 | >0.05 |
Albuminuria (mg/L) | 0.012 ± 0.0003 | 1900 ± 1175 | 0.0001 ± 0.0001 | <0.001 |
Albumin (g/dL) | 3.72 ± 0.32 | 3.41 ± 0.29 | 4.11 ± 0.37 | >0.05 |
Vespertilio—an erythematous rash in butterfly wings on the nose and dorsal face and at the zygomatic level.